Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 890 results found since Jan 2013.
CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment
IRVINE, CA – September 9, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies* today announced that it has launched CERENOVUS Stroke Solutions™, which includes a suite of three devices designed to aid physicians in clot removal procedures. The announcement was made during the virtual European Society of Minimally Invasive Neurological Therapy (ESMINT).Strokes are the second leading cause of death globally, and account for an estimated 140,000 deaths in the United States each year.[i],[ii] Over half of stroke survivors become chronically disabled placing an estimated $34 billion economic burden o...
Source: Johnson and Johnson - September 9, 2020 Category: Pharmaceuticals Source Type: news
Milvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
RARITAN, NJ, May 25, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that all three prospective indications for milvexian, an investigational oral factor XIa (FXIa) inhibitor (being developed in collaboration with Bristol Myers Squibb), have now been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). The designations cover all three indication-seeking studies within the Phase 3 Librexia development program (Librexia STROKE, Librexia ACS and Librexia AF), which are all dosing patients. The Librexia program is unrivaled as the most comprehensive FXIa clinical...
Source: Johnson and Johnson - May 25, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Johnson & Johnson Launches Heartline ™, the First-of-its-Kind, Virtual Study Designed to Explore if a New iPhone App and Apple Watch Can Help Reduce the Risk of Stroke
New Brunswick, NJ, February 25, 2020 — Johnson & Johnson (NYSE: JNJ) today announced that the Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Apple, opened enrollment for the Heartline™ Study. The study is designed to explore if the Heartline™ Study app on iPhone and heart health features on Apple Watch can improve health outcomes, including reducing the risk of stroke, with earlier detection of atrial fibrillation (AFib). AFib, a common form of irregular heart rhythm, is a leading cause of stroke in the U.S. To enroll in the Heartline™ Study, individuals must be age 65 or older...
Source: Johnson and Johnson - February 25, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Stroke prevention and the future of stroke care
Stroke is the fifth leading cause of death in the United States. The Georgia Department of Public Health reports the state had the 12th highest stroke death rate in the country. Georgia is also part of the “stroke belt,” an area of the southeastern United States with stroke death rates 30% higher than the rest of the nation.
As the leading — but preventable — cause of disability, stroke can happen at any age.
Stroke is a medical emergency, meaning the blood flow to an area of the brain…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 19, 2023 Category: Pharmaceuticals Source Type: news
More stroke patients may receive crucial treatments under new guideline
More patients could be eligible for critical treatments to remove or dissolve blood clots that cause strokes, according to a new treatment guideline issued by the American Heart Association/American Stroke Association. The guideline, based on the most recent science available, was published in the Association's journal Stroke, and released during the American Stroke Association's International Stroke Conference 2018, the premier global meeting for researchers and clinicians dedicated to the prevention and treatment of stroke.
Source: World Pharma News - January 24, 2018 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
Marcus Foundation gives $15 million to create Marcus Stroke Network
The Atlanta-based Marcus Foundation gave $15 million to establish the Marcus Stroke Network, a partnership that includes Grady Health System, Emory University School of Medicine, the American Heart Association/American Stroke Association and Boca Raton Regional Hospitals.
The goal of the network is to reduce stroke disability and death rates in the Southeast, known as the stroke belt because of its unusually high incidence of stroke and other forms of cardiovascular disease.
"The general population…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 22, 2018 Category: Pharmaceuticals Authors: Ellie Hensley Source Type: news
Mayo Clinic in Arizona receives comprehensive stroke center certification
PHOENIX — Mayo Clinic Hospital in Phoenix announces that it has received certification from DNV as a comprehensive stroke center, reflecting the highest level of competence for treatment of serious stroke events. The DNV Comprehensive Stroke Center Certification is based on standards set forth by the Brai n Attack Coalition and the American Stroke Association, and affirms that the medical center addresses the full spectrum of stroke care – diagnosis, treatment, rehabilitation and education – and…
Source: Mayo Clinic Business News - May 24, 2022 Category: Pharmaceuticals Source Type: news
ASA: Opioid Epidemic Tied to Infection-Related Stroke
TUESDAY, Feb. 12, 2019 -- The opioid epidemic is driving a steep increase in infection-related stroke hospitalizations, according to a study published online Jan. 30 in Stroke to coincide with the American Stroke Association International Stroke...
Source: Drugs.com - Pharma News - February 12, 2019 Category: Pharmaceuticals Source Type: news
Stroke ' Alarm Clock ' Improves Acute Stroke Management Metrics
THURSDAY, Sept. 24, 2020 -- Use of a stroke alarm clock demanding active feedback significantly improves management metrics for acute stroke, according to a study published online Sept. 24 in Stroke.
Mathias Fousse, M.D., from the Saarland...
Source: Drugs.com - Pharma News - September 24, 2020 Category: Pharmaceuticals Source Type: news
Cause of First Stroke Guides Prevention of Second Stroke
MONDAY, May 24, 2021 -- In a guideline issued by the American Heart Association/American Stroke Association and published online May 24 in Stroke, recommendations are presented for prevention of a second stroke.
Dawn O. Kleindorfer, M.D., from the...
Source: Drugs.com - Pharma News - May 24, 2021 Category: Pharmaceuticals Source Type: news
Functional Stroke Recovery Varies by Age, Sex, and Stroke Type
TUESDAY, Oct. 11, 2022 -- Following stroke, long-term recovery patterns in multifaceted functional domains differ by patient age, stroke severity, and stroke type, according to a study published online Sept. 23 in JAMA Network Open.
Seyoung Shin,...
Source: Drugs.com - Pharma News - October 11, 2022 Category: Pharmaceuticals Source Type: news
Women With LVO Acute Ischemic Stroke Less Likely to Be Routed to Stroke Centers
WEDNESDAY, July 26, 2023 -- Women with large vessel occlusion (LVO) acute ischemic stroke (AIS) are less likely to be routed to comprehensive stroke centers (CSCs) compared with men, despite presenting with more significant stroke syndromes,...
Source: Drugs.com - Pharma News - July 26, 2023 Category: Pharmaceuticals Source Type: news
Mayo Clinic in Arizona Receives Get With The Guidelines-Stroke Gold Plus Quality Achievement Award
PHOENIX — Mayo Clinic in Arizona has received the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke Gold Plus Quality Achievement Award. The award recognizes Mayo Clinic's commitment and success in implementing excellent care for stroke patients, according to evidence-based guidelines. To receive the award, Mayo Clinic achieved of 85 percent or higher adherence [...]
Source: Mayo Clinic Business News - October 22, 2012 Category: Pharmaceuticals Source Type: news
Mercy Hospital acknowledged for stroke work
A new designation recognizes the stroke program at Mercy Hospital of Buffalo for its facilities and clinical staffing expertise.
The hospital was named a Comprehensive Stroke Center by The Joint Commission, becoming the first in Western New York and just the second hospital statewide to earn the designation.
The certification, offered in collaboration with the American Heart Association/American Stroke Association, recognizes hospitals for specialized staff, equipment and facilities to treat complex…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 22, 2014 Category: Pharmaceuticals Authors: Tracey Drury Source Type: research
